Invitrogen™ Human ProcartaPlex™ Panel 8 plex graft disease versus host

Ref.: BL-RE-097926Manufacturer ref.: EPX080-15814-901 96 dosages
€2,445.00 excl. VAT

Graft-to-host disease can occur in stem cell transplants when donor immune cells (the graft) recognize the recipient (the host) as a stranger and transplanted immune cells attack the immune system.

Product type
Multiplex panel
Quantity
96 dosages
Species
Human
Combinability
Not combinable
Sensitivity of the dosage
Less than 15%
Brand
Invitrogen

Graft-to-host disease can occur in stem cell transplants when donor immune cells (the graft) recognize the recipient (the host) as a stranger and transplanted immune cells attack the immune system.

Graft-to-host disease may occur in stem cell transplants when donor immune cells (the graft) recognize the recipient (the host) as a stranger and transplanted immune cells then attack host body cells. Graft-to-host disease may also occur after blood transfusion if the blood products used have not been irradiated or treated with an approved pathogen reduction system. Therefore, simultaneous detection of these targets can help to gather more information about these processes. The panel is supplied in a ready-to-use format with individual vials of capture and detection reagents formulated at a concentration of 1X, requiring less pipeting and experimental configuration. It cannot be associated with simplexes or other panels.

ProcartaPlex preconfigured panels are widely tested for combinability, interference and cross-reactivity of analyses to provide the highest level of validation and accuracy. All ProcartaPlex panels are supplied with the reagents necessary to perform the dosage.

ProcartaPlex multiplex panels are available in several formats and can be used on six species (human, mouse, rat, non-human primate, porcine and canine).

Target list [microbead region]: CD30 [34], Granzyme A [74], HGF [46], IL-2R [22], IL-33R (ST2) [35], KRT18 [67], Syndecane [14], TNF-RI [39]

About ProcartaPlex strengths for Luminex platform

ProcartaPlex immunoassays, based on the principles of an ELISA e sandwich, use two highly specific antibodies binding to different epitopes of a protein to simultaneously quantify all target proteins using a Luminex instrument. ProcartaPlex multiplex assays require only 25 µl plasma or serum, or 50 µl cell culture supernatant, and only four hours to obtain the analyzed results.

ProcartaPlex assays use Luminex xMAP (multianalyte profiling) technology to simultaneously detect and quantify up to 80 protein targets in a single sample of 25-50 µl — plasma, serum, cell culture supernatants and other body fluids.

Luminex microbeads in the ProcartaPlex assay are coloured internally with precise proportions of red fluorophores and IR to create unique spectral signatures that can be identified by Luminex xMAP detection systems (e.g. Luminex 200, FLEXMAP 3D and MAGPIX). Like ELISA sandwich, the ProcartaPlex assay uses paired antibody pairs to identify the protein of interest. In a multiplexed assay, each single spectral microbead is marked with antibodies specific to a single target protein and the bound proteins are identified with biotinyl antibodies and streptavidine–R-phycoerythrin (RPE). Conjugation of specific antibodies from a protein to a separate microbead makes it possible to analyze several targets in a single well.

The most significant difference between a ProcartaPlex assay and a ELISA assay is that the ProcartaPlex capture antibody is conjugated with a microbead and is not adsorbed by any of the microplate wells. Thus, ProcartaPlex dosing reagents float freely in the solution. For detection purposes, Luminex 200, for example, contains two lasers: one to distinguish the spectral signature from each microbead and one to quantify the amount of fluorescence of RPE. The latter is proportional to the amount of protein present in the sample. Multiplex ProcartaPlex assays can profile more target proteins using a significantly smaller sample. It takes them as long as they do a traditional ELISA sandwich.

Reproducible and reliable results — validated...

Reproducible and reliable results — validated as the highest standard panel in industry, including protein compatibility and cross-reactivity tests

More results per sample—measurement...

More results per sample—simultaneous measurement of multiple protein targets in a single sample of 25–50 µl

Highly referenced multiplexing platform...

Highly referenced multiplexing platform for protein detection and quantification by well established Luminex technology

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17178895
Specifications
Product typeMultiplex panel
Quantity96 dosages
SpeciesHuman
CombinabilityNot combinable
Sensitivity of the dosageLess than 15%
Dose rangeSee Certificate of Analysis
FormatMultiplex kit
For use with (equipment)Luminex™ Instruments
Product rangeProcartaPlex™
Type of sampleSerum, plasma, cell culture supernatants (SCC), Plasma, Cell Culture Supernatants
dimResearchAreaImmunology
Physical characteristics
Volume of sampleSerum, plasma: 25 μl, cell culture supernatant: 50 μlitres
Storage and shipping
Content and storage<ul><li>2 flacons de mélange 1 étalon humain GvDH humaine (lyophilisée)</li><li>2 flacons de mélange 2 étalon humain GvDH humaine (lyophilisée)</li><li>1 flacon de mélange de microbilles de capture (1X)</li><li>1 flacon de mélange d’anticorps de détection biotinylé (1X)</li><li>1 flacon de tampon de
Shipping conditionsMoist ice

Origin and customs

Manufacturer ref.EPX080-15814-901
Country of originAutriche
A question or a specific configuration?
Contact us for a quote.